Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy

被引：0
|
作者：
Bageghni, S. A. [1 ]
Hemmings, K. E. [1 ]
Porter, K. E. [1 ]
Ainscough, J. F. [1 ]
Drinkhill, M. J. [1 ]
Turner, N. A. [1 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
来源：
CARDIOVASCULAR RESEARCH | 2016年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
324
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism
    Bageghni, Sumia A.
    Hemmings, Karen E.
    Zava, Ngonidzashe
    Denton, Christopher P.
    Porter, Karen E.
    Ainscough, Justin F. X.
    Drinkhill, Mark J.
    Turner, Neil A.
    [J]. FASEB JOURNAL, 2018, 32 (09): : 4941 - 4954
  • [2] Phillyrin Inhibits Isoproterenol-Induced Cardiac Hypertrophy Via P38 and NF-κB Pathways
    Liu, Juanjuan
    Li, Jiahang
    Yang, Shengqian
    She, Yuanting
    Li, Xiaohui
    Jia, Yi
    [J]. NATURAL PRODUCT COMMUNICATIONS, 2023, 18 (01)
  • [3] CARDIAC FIBROBLAST P38α MAP KINASE IS ESSENTIAL FOR CARDIOMYOCYTE HYPERTROPHY AND CARDIAC DYSFUNCTION FOLLOWING MYOCARDIAL INJURY
    Bageghni, S. A.
    Hemmings, K. E.
    Porter, K. E.
    Ainscough, J. F. X.
    Drinkhill, M. J.
    Turner, N. A.
    [J]. HEART, 2016, 102 : A2 - A2
  • [4] Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway
    Mao, Hao-ping
    Wang, Xing-ye
    Gao, Yun-hang
    Chang, Yan-xu
    Chen, Lu
    Niu, Zi-chang
    Ai, Ju-qing
    Gao, Xiu-mei
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2016, 186 : 20 - 29
  • [5] Mouse strain-specific differences in cardiac metabolic enzyme activities observed in a model of isoproterenol-induced cardiac hypertrophy
    Faulx, Michael D.
    Chandler, Margaret P.
    Zawaneh, Michael S.
    Stanley, William C.
    Hoit, Brian D.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (1-2) : 77 - 80
  • [6] Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
    Zhao, Tingwei
    Kee, Hae Jin
    Bai, Liyan
    Kim, Moon-Ki
    Kee, Seung-Jung
    Jeong, Myung Ho
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
    Song, Renxing
    Xiong, Chunming
    Bai, Juncai
    Bai, Zhenzhou
    Liu, Wei
    [J]. CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [8] Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
    Song, Renxing
    Xiong, Chunming
    Bai, Juncai
    Bai, Zhenzhou
    Liu, Wei
    [J]. CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [9] The effect of P38 MAP kinase inhibition in a mouse model of influenza
    Growcott, E. J.
    Bamba, D.
    Galarneau, J-R.
    Leonard, V. H. J.
    Schul, W.
    Stein, D.
    Osborne, C. S.
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (03) : 452 - 462
  • [10] Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through specific MAPK and PKC pathways
    House, S
    El Schultz, J
    Glascock, B
    Kimball, T
    Doetschman, T
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 299 - 299
12345